Injury Woes Mount for Texas
The Texas Rangers entered the 2025 season with high expectations, but a cascade of injuries to their pitching staff has cast a shadow over their playoff aspirations. Two of the team's most reliable arms, Josh Jung and Cody Bradford, have been sidelined for extended periods, forcing the club to reshuffle its rotation and rely on younger, less experienced options.
Jung, a left‑handed outfielder who has also been used in occasional pitching roles, suffered a strained left calf in late July. The injury forced him to miss at least a week of action and has now stretched into a longer recovery, disrupting the lineup plans that were set after the trade deadline.
Bradford, a right‑handed starter, endured an elbow injury during spring training that required internal‑brace surgery. The procedure slowed his return dramatically, and despite making four rehab appearances in mid‑July, he has yet to regain his pre‑injury form.
Upcoming Matchup with San Francisco
The Rangers are slated to face the San Francisco Giants in a three‑game series, with the Giants announcing that left‑handed reliever Carson Whisenhunt will start the finale. Whisenhunt's presence on the mound underscores the Rangers' continued difficulty against left‑handed batters, a weakness that has been amplified by the absence of key pitchers.
San Francisco's strategy to deploy a left‑handed arm reflects a broader league trend of exploiting matchups, and it puts additional pressure on Texas to adapt quickly. The Rangers' recent performance against left‑handed hitters has shown a noticeable dip, raising concerns about their ability to compete in high‑stakes games.
Looking Ahead
While the organization remains hopeful that both Jung and Bradford will return to full health before the postseason, the timeline for their recoveries remains uncertain. In the meantime, the team is focusing on developing depth in the bullpen and exploring trade opportunities that could bolster the rotation. The upcoming series against San Francisco will serve as a critical test of whether the Rangers can weather these setbacks and maintain their competitive edge.